Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.

Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, Durando P, Icardi G.

Vaccine. 2012 Mar 16;30(13):2288-94. doi: 10.1016/j.vaccine.2012.01.067. Epub 2012 Feb 3.

PMID:
22306795
2.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

3.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

4.

Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines.

Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, Durando P, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:211-6. doi: 10.4161/hv.7.0.14602. Review.

PMID:
21546795
6.

Pneumococcal serotype evolution in Western Europe.

Tin Tin Htar M, Christopoulou D, Schmitt HJ.

BMC Infect Dis. 2015 Oct 14;15:419. doi: 10.1186/s12879-015-1147-x. Review.

7.

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Torres A, Bonanni P, Hryniewicz W, Moutschen M, Reinert RR, Welte T.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):19-31. doi: 10.1007/s10096-014-2208-6. Epub 2014 Aug 23. Review. Erratum in: Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):415-6.

8.

Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.

Tatochenko V, Sidorenko S, Namazova-Baranova L, Mayanskiy N, Kulichenko T, Baranov A, Lobzin Y, Kharit S, Kozlov R, Andreeva I, Muravjev A, Chagaryan A, Koroleva I, Beloshitskiy G, Mironov K, Degtyareva E, Reinert RR.

Expert Rev Vaccines. 2014 Feb;13(2):257-64. doi: 10.1586/14760584.2013.871205. Epub 2013 Dec 18. Review.

PMID:
24350587
9.

Continued control of pneumococcal disease in the UK - the impact of vaccination.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

J Med Microbiol. 2011 Jan;60(Pt 1):1-8. doi: 10.1099/jmm.0.020016-0. Epub 2010 Oct 21. Review.

PMID:
20965923
10.

13-valent pneumococcal conjugate vaccine (PCV13).

Jefferies JM, Macdonald E, Faust SN, Clarke SC.

Hum Vaccin. 2011 Oct;7(10):1012-8. doi: 10.4161/hv.7.10.16794. Epub 2011 Oct 1. Review.

PMID:
21941097
11.

Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine.

Durando P, Alicino C, De Florentiis D, Martini M, Icardi G.

J Prev Med Hyg. 2012 Jun;53(2):68-77. Review.

PMID:
23240163
12.

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.

Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC.

Vaccine. 2012 May 21;30(24):3503-14. doi: 10.1016/j.vaccine.2012.03.066. Epub 2012 Apr 1. Review.

PMID:
22475858
13.

Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.

Madhi SA, Cohen C, von Gottberg A.

Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055. Review.

PMID:
22939016
14.

Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination.

Mehr S, Wood N.

Paediatr Respir Rev. 2012 Dec;13(4):258-64. doi: 10.1016/j.prrv.2011.12.001. Epub 2012 Jan 18. Review.

PMID:
23069126
15.

Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.

Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL.

Vaccine. 2013 Dec 17;32(1):133-45. doi: 10.1016/j.vaccine.2013.05.005. Epub 2013 May 16. Review.

PMID:
23684824
16.

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

Hausdorff WP, Hoet B, Schuerman L.

BMC Pediatr. 2010 Feb 2;10:4. doi: 10.1186/1471-2431-10-4. Review.

17.

Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

Devine VT, Jefferies JM, Clarke SC, Faust SN.

J Immunol Res. 2015;2015:394368. doi: 10.1155/2015/394368. Epub 2015 Aug 16. Review.

18.

Serotype replacement in disease after pneumococcal vaccination.

Weinberger DM, Malley R, Lipsitch M.

Lancet. 2011 Dec 3;378(9807):1962-73. doi: 10.1016/S0140-6736(10)62225-8. Epub 2011 Apr 12. Review.

19.

Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children.

Weil Olivier C.

Med Mal Infect. 2013 Aug;43(8):309-21. doi: 10.1016/j.medmal.2013.04.006. Epub 2013 Jul 8. Review.

PMID:
23845250
20.

Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE.

BMC Infect Dis. 2012 May 28;12:124. doi: 10.1186/1471-2334-12-124. Review.

Supplemental Content

Support Center